Home / The Ministry of Health strengthens the management measures for the purchase, sale and use of drugs to treat Covid-19

The Ministry of Health strengthens the management measures for the purchase, sale and use of drugs to treat Covid-19

19/03/2022


On March 17, 2022, the Ministry of Health issued Official Dispatch 365/CD-BYT on continuing to inspect, examine and strengthen the management of Covid-19 treatment drugs.

According to Dispatch, to ensure adequate supply of drugs for the treatment needs of Covid-19; ensure the quality of drugs at reasonable prices and comply with the provisions of law in drug trading; The Ministry of Health requests the People's Committees of the provinces and centrally-run cities to strengthen and drastically direct the following contents:


IIlustration

- Keep directing the Department of Health to assume the prime responsibility for, and coordinate with relevant agencies in, strengthening propaganda, dissemination and training on legal regulations and guidelines of the Ministry of Health on buying, selling and using therapeutic drugs for COVID-19; take samples for testing to check drug quality; strengthen inspection and examination of the purchase and sale of drugs to treat Covid-19 at pharmaceutical business establishments.

- Direct functional agencies in provinces and cities such as Steering Committee 389, Market Management, Provincial and Municipal Police and other functional agencies to strengthen inspection and examination of activities in order to develop currently, to prevent acts of smuggling, commercial fraud, and counterfeit goods in the production and trading of Covid-19 treatment drugs, activities of buying and selling Covid-19 treatment drugs at business locations not being licensed according to regulations or on social platforms and other online platforms, activities of buying and selling drugs of unknown origin;

- Directing pharmaceutical business establishments to fully comply with the provisions of law in buying and selling drugs in general and drugs to treat Covid-19 in particular; list prices and sell them according to the listed and declared drug prices; fully guide people on using drugs according to instructions; fully comply with the requirements of good drug practice in pharmaceutical business (GSP, GDP, GPP) and other regulations in pharmaceutical business; The Ministry of Health requests the People's Committees of the provinces and cities to urgently direct the implementation of the contents of this Official Dispatch; organize inspection and examination to early detect violating organizations and individuals and strictly handle violations.